Phase I dose-escalation and -expansion study of buparlisib...

Investigational New Drugs 2014 / 08 Vol. 32; Iss. 4

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

Rodon, Jordi, Braña, Irene, Siu, Lillian L, Jonge, Maja J, Homji, Natasha, Mills, David, Tomaso, Emmanuelle, Sarr, Celine, Trandafir, Lucia, Massacesi, Cristian, Eskens, Ferry, Bendell, Johanna C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-014-0082-9
Date:
August, 2014
File:
PDF, 925 KB
english, 2014
Conversion to is in progress
Conversion to is failed